arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

IRONWOOD PHARMACEUTICALS INC

IRWD
$4.04 ▲ +0.25 (+6.60%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
18 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
65
Health
Fair
Bullish
auto_awesome

Analytical Summary

IRONWOOD PHARMACEUTICALS INC shows strong fundamentals with top-quartile Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $653.8M
Dividend Yield —
Revenue Growth -15.7% ↗
Op. Margin 33.3% ↗
ROIC -12.9% ↘
FCF / Share $0.78 ↗
Trailing P/E 26.9x
Price / Book —
FCF Yield 19.4%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$296.15M
↓ -15.7% —
Net Income Profit after all expenses
$24.02M
↑ +2629.2% —
Operating Margin Operating profit as % of sales
33.3%
↑ +25.5% 89th
FCF / Share Free cash flow per share
$0.78
↑ +20.7% —
Long-Term Debt Long-term obligations
$396.25M
↓ -12.8% —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
82
Returns
35
Financial Health ↓
67
Cash Quality ↑
95

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 68 quarters